June 3, 2019

FDA: Class I recall of SOLOPATH Balloon Expandable TransFemoral System, Re-Collapsible Balloon Access System

By: Judy Mathias

Editor’s Note

The Food & Drug Administration on May 30 identified the recall by Terumo Medical Corporation (Somerset, New Jersey) of its SOLOPATH Balloon Expandable TransFemoral System and Re-Collapsible Balloon Access System as Class I, the most serious.

The recall was initiated because the tip could dislodge from the outer rim of the sheath resulting in a loss of smooth transition from the surface of the tip to the outer surface of the expandable sheath. A total of 14 incidents have been reported, including two injuries.

Distribution dates are July 22, 2016, to March 13, 2019.


Sign Up For OR a.m.
Sign up for the free OR a.m. eLetter to get news like this in your inbox every morning!

OR Manager Jobs
Upcoming Webinars
Live chat by BoldChat